Delays in treatment initiation for patients with relapsing-remitting multiple sclerosis-A nationwide population-based study
{{output}}
Background: Early disease-modifying therapy (DMT) improves outcomes in patients with relapsing-remitting multiple sclerosis (pwRRMS), but reasons for delayed or absent initiation are unclear. ... ...
